These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 27654120)
1. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120 [TBL] [Abstract][Full Text] [Related]
2. Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis. Benson EA; Tibuakuu M; Zhao D; Akinkuolie AO; Otvos JD; Duprez DA; Jacobs DR; Mora S; Michos ED Clin Cardiol; 2018 Nov; 41(11):1439-1445. PubMed ID: 30452775 [TBL] [Abstract][Full Text] [Related]
3. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. Connelly MA; Otvos JD; Shalaurova I; Playford MP; Mehta NN J Transl Med; 2017 Oct; 15(1):219. PubMed ID: 29078787 [TBL] [Abstract][Full Text] [Related]
12. PET/CT-Based Characterization of 18F-FDG Uptake in Various Tissues Reveals Novel Potential Contributions to Coronary Artery Disease in Psoriatic Arthritis. Schwartz DM; Parel P; Li H; Sorokin AV; Berg AR; Chen M; Dey A; Hong CG; Playford M; Sylvester M; Teague H; Siegel E; Mehta NN Front Immunol; 2022; 13():909760. PubMed ID: 35720288 [TBL] [Abstract][Full Text] [Related]
13. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study. Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983 [TBL] [Abstract][Full Text] [Related]
14. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial. Akinkuolie AO; Glynn RJ; Padmanabhan L; Ridker PM; Mora S J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27413042 [TBL] [Abstract][Full Text] [Related]
15. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917 [TBL] [Abstract][Full Text] [Related]
16. Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young. Chiesa ST; Charakida M; Georgiopoulos G; Roberts JD; Stafford SJ; Park C; Mykkänen J; Kähönen M; Lehtimäki T; Ala-Korpela M; Raitakari O; Pietiäinen M; Pussinen P; Muthurangu V; Hughes AD; Sattar N; Timpson NJ; Deanfield JE J Am Heart Assoc; 2022 Feb; 11(4):e024380. PubMed ID: 35156387 [TBL] [Abstract][Full Text] [Related]
17. Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography. Dey AK; Joshi AA; Chaturvedi A; Lerman JB; Aberra TM; Rodante JA; Teague HL; Harrington CL; Rivers JP; Chung JH; Kabbany MT; Natarajan B; Silverman JI; Ng Q; Sanda GE; Sorokin AV; Baumer Y; Gerson E; Prussick RB; Ehrlich A; Green LJ; Lockshin BN; Ahlman MA; Playford MP; Gelfand JM; Mehta NN JAMA Cardiol; 2017 Sep; 2(9):1013-1018. PubMed ID: 28564678 [TBL] [Abstract][Full Text] [Related]
18. Monocyte-to-High-Density Lipoprotein Ratio Is Associated with Systemic Inflammation, Insulin Resistance, and Coronary Subclinical Atherosclerosis in Psoriasis: Results from 2 Observational Cohorts. Berna-Rico E; Abbad-Jaime de Aragon C; Ballester-Martinez A; Perez-Bootello J; Solis J; Fernandez-Friera L; Llamas-Velasco M; Castellanos-Gonzalez M; Barderas MG; Azcarraga-Llobet C; Garcia-Mouronte E; de Nicolas-Ruanes B; Naharro-Rodriguez J; Jaen-Olasolo P; Gelfand JM; Mehta NN; Gonzalez-Cantero A J Invest Dermatol; 2024 Sep; 144(9):2002-2012.e2. PubMed ID: 38460808 [TBL] [Abstract][Full Text] [Related]
19. GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment. Ballout RA; Remaley AT J Lab Precis Med; 2020 Apr; 5():. PubMed ID: 32363327 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events. Duprez DA; Otvos J; Sanchez OA; Mackey RH; Tracy R; Jacobs DR Clin Chem; 2016 Jul; 62(7):1020-31. PubMed ID: 27173011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]